Skip to main content
Premium Trial:

Request an Annual Quote

Dow Wilson

Varian Medical Systems CEO Dow Wilson has been elected to the board of Agilent Technologies, effective March 20. Wilson has been CEO of Varian Medical since 2012. Before being appointed CEO, he was the firm's chief operating officer and executive vice president. Prior to that, he was president of Varian Medical's Oncology Systems business. He previously spent 19 years at GE Healthcare and eventually became CEO of GE's Healthcare Information Technology unit. 

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.